Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 308,277 |
|
|||||
| News | - | ||||||
| Day High | 38.18 | Low High |
|||||
| Day Low | 36.94 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Spyre Therapeutics Inc | SYRE | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.06 | 0.16% | 37.86 | 16:16:11 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 37.97 | 36.94 | 38.18 | 37.86 | 37.80 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 5,822 | 308,277 | US$ 37.82 | US$ 11,657,813 | - | 10.42 - 47.97 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:06:01 | 1 | US$ 36.66 | USD |
Spyre Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.37B | 36.15M | - | 886k | -338.79M | -9.37 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Spyre Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SYRE Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 38.64 | 40.49 | 35.12 | 37.73 | 337,264 | -0.78 | -2.02% |
| 1 Month | 34.10 | 40.49 | 31.27 | 35.02 | 307,118 | 3.76 | 11.03% |
| 3 Months | 20.96 | 47.97 | 20.13 | 35.84 | 494,871 | 16.90 | 80.63% |
| 6 Months | 10.81 | 47.97 | 10.42 | 31.28 | 377,035 | 27.05 | 250.23% |
| 1 Year | 10.81 | 47.97 | 10.42 | 31.28 | 377,035 | 27.05 | 250.23% |
| 3 Years | 10.81 | 47.97 | 10.42 | 31.28 | 377,035 | 27.05 | 250.23% |
| 5 Years | 10.81 | 47.97 | 10.42 | 31.28 | 377,035 | 27.05 | 250.23% |
Spyre Therapeutics Description
| Aeglea BioTherapeutics Inc is a clinical-stage biotechnology company. It designs and develops innovative human enzyme therapeutics for patients with rare genetic diseases and cancer. The company's lead product candidate includes pegzilarginase, a recombinant human Arginase 1 enzyme, which is in an early clinical development stage. |
